Skip to main content
3 Biotech logoLink to 3 Biotech
. 2024 May 15;14(6):154. doi: 10.1007/s13205-024-03994-9

Correction for: Cornel iridoid glycoside exerts a neuroprotective effect on neuroinflammation in rats with brain injury by inhibiting NF-kB and STAT3

Tingting Zheng 1,2, Jiao Peng 3, Tao Pei 4, Yu Shi 1,2, Li Liu 1,2, Keke Chen 1,2, Haitao Xiao 5,✉,#, Yun Chen 1,2,✉,#
PMCID: PMC11096139  PMID: 38766323

Correction to: 3 Biotech (2019) 9:195 10.1007/s13205-019-1697-5

The authors found that there are two images overlap in Fig. 5. It depicts cornel iridoid glycoside treatment reduced the STAT3 protein level in rats brain injury which is analyzed under a confocal microscope. The image of 100 mg/kg cornel iridoid glycoside (group IV) is replaced with the corresponding picture from the original set of experiments. This alteration does not affect the results and the conclusion drawn from this work.

The corrected Fig. 5 is presented below.

Fig. 5.

Fig. 5

Cornel iridoid glycoside treatment reduced the STAT3 protein level in rats with brain injury. *P < 0.05 versus group I and #P < 0.05 versus group II (brain injury). Scale bar = 100 µm

Contributor Information

Haitao Xiao, Email: ToddaParkergw@yahoo.com.

Yun Chen, Email: cc76357566ranl@163.com.


Articles from 3 Biotech are provided here courtesy of Springer

RESOURCES